During the past decade, Second Department of Surgery, Wakayama Medical University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Second Department of Surgery, Wakayama Medical University" are "Gastric Cancer" (3 trials), "Pancreatitis" (3 trials), "Ampullary Cancer" (2 trials), "Bile Duct Cancer" (2 trials) and "Duodenal Cancer" (2 trials). Many other conditions were trialed in "Second Department of Surgery, Wakayama Medical University" in a lesser frequency.

Most popular intervention types in "Second Department of Surgery, Wakayama Medical University" are "Procedure" (6 trials), "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Billroth-I reconstruction" (1 trials), "Billroth-II-type reconstruction" (1 trials), "Conventional procedure" (1 trials), "Isolated Roux-en-Y type reconstruction" (1 trials) and "Isolation procedure (RAMPS procedure)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Second Department of Surgery, Wakayama Medical University" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Second Department of Surgery, Wakayama Medical University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Second Department of Surgery, Wakayama Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Second Department of Surgery, Wakayama Medical University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".